The nervous system is the most important system in the body affecting the sensory and motor functions of the body when the system is damaged (
1). Human nervous system consists of the central nervous system and the peripheral nervous system. Injuries to CNS affects 2 million people in the US each year (
2) and has been associated with a wide variety of complications including neurodegenerative diseases and destructions in regions of brain and spinal cord due to traumatic injuries and stroke (
3). The neurons in the CNS do not regenerate under normal conditions while several factors cause this failure. CNS injury leads into activation of astrocytes, a type of glial cell, which multiply to create an inhibitory glial scar (
2). At present, there is no treatment modality with clinically documented efficacy to actively improve the repair of the human CNS. Current medical managements focus primarily on stabilization and prevention of more injuries e.g. orthopedic fixation of an unstable spine and consequently on rehabilitation and the preparation of prosthetics (
3). In PNS damage, for which the current treatments are nerve autografts and allografts, surgeons may encounter problems such as a shortage of donor nerves, size inequality between the donor nerve and the recipient, neuronal formation, infectious diseases, immunological issues and indeed a complete recovery of functions of nervous tissue is not common (
3). In the case of larger nerve gaps (more than 20 mm), a clinical aim could be the application of sensory nerve autografts. An evaluation of clinical outcomes of autograft application showed that there was a vital need for engineered alternatives (
4). Therefore, restoring the task of damaged PNS and CNS has always been a challenge for neurobiologists and neurologists. Ineffectiveness of current methods of treatment has compelled scientists to search for new treatment strategies for the injured nervous system (
5).